Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters











Database
Language
Publication year range
1.
ACS Nano ; 14(1): 1111-1122, 2020 01 28.
Article in English | MEDLINE | ID: mdl-31914314

ABSTRACT

Here we present a blood-brain barrier (BBB) model that enables high-resolution imaging of nanoparticle (NP) interactions with endothelial cells and the capture of rare NP translocation events. The enabling technology is an ultrathin silicon nitride (SiN) membrane (0.5 µm pore size, 20% porosity, 400 nm thickness) integrated into a dual-chamber platform that facilitates imaging at low working distances (∼50 µm). The platform, the µSiM-BBB (microfluidic silicon membrane-BBB), features human brain endothelial cells and primary astrocytes grown on opposite sides of the membrane. The human brain endothelial cells form tight junctions on the ultrathin membranes and exhibit a significantly higher resistance to FITC-dextran diffusion than commercial membranes. The enhanced optical properties of the SiN membrane allow high-resolution live-cell imaging of three types of NPs, namely, 40 nm PS-COOH, 100 nm PS-COOH, and apolipoprotein E-conjugated 100 nm SiO2, interacting with the BBB. Despite the excellent barrier properties of the endothelial layer, we are able to document rare NP translocation events of NPs localized to lysosomal compartments of astrocytes on the "brain side" of the device. Although the translocation is always low, our data suggest that size and targeting ligand are important parameters for NP translocation across the BBB. As a platform that enables the detection of rare transmission across tight BBB layers, the µSiM-BBB is an important tool for the design of nanoparticle-based delivery of drugs to the central nervous system.


Subject(s)
Blood-Brain Barrier/metabolism , Models, Biological , Nanoparticles/metabolism , Optical Imaging , Silicon/metabolism , Biological Transport , Blood-Brain Barrier/chemistry , Cell Line , Coculture Techniques , Humans , Nanoparticles/chemistry , Particle Size , Silicon/chemistry , Surface Properties
2.
J Cell Biol ; 216(11): 3817-3829, 2017 11 06.
Article in English | MEDLINE | ID: mdl-28954823

ABSTRACT

The integrin lymphocyte function-associated antigen 1 (LFA-1; CD11a/CD18) is a key T cell adhesion receptor that mediates stable interactions with antigen-presenting cell (APC), as well as chemokine-mediated migration. Using our newly generated CD11a-mYFP knock-in mice, we discovered that naive CD8+ T cells reserve a significant intracellular pool of LFA-1 in the uropod during migration. Intracellular LFA-1 quickly translocated to the cell surface with antigenic stimulus. Importantly, the redistribution of intracellular LFA-1 at the contact with APC was maintained during cell division and led to an unequal inheritance of LFA-1 in divided T cells. The daughter CD8+ T cells with disparate LFA-1 expression showed different patterns of migration on ICAM-1, APC interactions, and tissue retention, as well as altered effector functions. In addition, we identified Rab27 as an important regulator of the intracellular LFA-1 translocation. Collectively, our data demonstrate that an intracellular pool of LFA-1 in naive CD8+ T cells plays a key role in T cell activation and differentiation.


Subject(s)
CD11a Antigen/metabolism , CD18 Antigens/metabolism , CD8-Positive T-Lymphocytes/metabolism , Cell Differentiation , Lymphocyte Activation , Lymphocyte Function-Associated Antigen-1/metabolism , Animals , Antigen-Presenting Cells/immunology , Antigen-Presenting Cells/metabolism , CD11a Antigen/genetics , CD11a Antigen/immunology , CD18 Antigens/genetics , CD18 Antigens/immunology , CD8-Positive T-Lymphocytes/immunology , Cells, Cultured , Chemotaxis, Leukocyte , Lymphocyte Function-Associated Antigen-1/genetics , Lymphocyte Function-Associated Antigen-1/immunology , Mice, Inbred C3H , Mice, Inbred C57BL , Mice, Transgenic , Mitosis , Protein Transport , Receptors, Antigen, T-Cell/genetics , Receptors, Antigen, T-Cell/metabolism , Signal Transduction , Time Factors , rab GTP-Binding Proteins/metabolism
3.
J Bone Miner Res ; 32(5): 985-990, 2017 May.
Article in English | MEDLINE | ID: mdl-27933662

ABSTRACT

Although Staphylococcus aureus osteomyelitis is considered to be incurable, the major bacterial reservoir in live cortical bone has remained unknown. In addition to biofilm bacteria on necrotic tissue and implants, studies have implicated intracellular infection of osteoblasts and osteocytes as a mechanism of chronic osteomyelitis. Thus, we performed the first systematic transmission electron microscopy (TEM) studies to formally define major reservoirs of S. aureus in chronically infected mouse (Balb/c J) long bone tissue. Although rare, evidence of colonized osteoblasts was found. In contrast, we readily observed S. aureus within canaliculi of live cortical bone, which existed as chains of individual cocci and submicron rod-shaped bacteria leading to biofilm formation in osteocyte lacunae. As these observations do not conform to the expectations of S. aureus as non-motile cocci 1.0 to 1.5 µm in diameter, we also performed immunoelectron microscopy (IEM) following in vivo BrdU labeling to assess the role of bacterial proliferation in canalicular invasion. The results suggest that the deformed bacteria: (1) enter canaliculi via asymmetric binary fission; and (2) migrate toward osteocyte lacunae via proliferation at the leading edge. Additional in vitro studies confirmed S. aureus migration through a 0.5-µm porous membrane. Collectively, these findings define a novel mechanism of bone infection, and provide possible new insight as to why S. aureus implant-related infections of bone tissue are so challenging to treat. © 2016 American Society for Bone and Mineral Research.


Subject(s)
Cortical Bone/microbiology , Osteomyelitis/metabolism , Osteomyelitis/microbiology , Staphylococcal Infections/metabolism , Staphylococcal Infections/microbiology , Staphylococcus aureus/metabolism , Animals , Cortical Bone/metabolism , Cortical Bone/pathology , Disease Models, Animal , Female , Mice , Mice, Inbred BALB C , Osteomyelitis/genetics , Osteomyelitis/pathology , Staphylococcal Infections/genetics , Staphylococcal Infections/pathology , Staphylococcus aureus/genetics
4.
Proc Natl Acad Sci U S A ; 109(26): 10474-9, 2012 Jun 26.
Article in English | MEDLINE | ID: mdl-22689994

ABSTRACT

T cells spend the majority of their time perusing lymphoid organs in search of cognate antigen presented by antigen presenting cells (APCs) and then quickly recirculate through the bloodstream to another lymph node. Therefore, regulation of a T-cell response is dependent upon the ability of cells to arrive in the correct location following chemokine gradients ("go" signal) as well as to receive appropriate T-cell receptor (TCR) activation signals upon cognate antigen recognition ("stop" signal). However, the mechanisms by which T cells regulate these go and stop signals remain unclear. We found that overexpression of the hematopoietic-specific RhoH protein in the presence of chemokine signals resulted in decreased Rap1-GTP and LFA-1 adhesiveness to ICAM-1, thus impairing T-cell chemotaxis; while in the presence of TCR signals, there were enhanced and sustained Rap1-GTP and LFA-1 activation as well as prolonged T:APC conjugates. RT-PCR analyses of activated CD4(+) T cells and live images of T-cell migration and immunological synapse (IS) formation revealed that functions of RhoH took place primarily at the levels of transcription and intracellular distribution. Thus, we conclude that RhoH expression provides a key molecular determinant that allows T cells to switch between sensing chemokine-mediated go signals and TCR-dependent stop signals.


Subject(s)
Lymphocyte Activation , T-Lymphocytes/cytology , Transcription Factors/physiology , rho GTP-Binding Proteins/physiology , Humans , Receptors, Antigen, T-Cell/physiology , Receptors, Chemokine/physiology
5.
Vaccine ; 29(40): 7080-9, 2011 Sep 16.
Article in English | MEDLINE | ID: mdl-21801777

ABSTRACT

The efficient induction of virus-specific mucosal antibodies is an important unmet objective in Human Immunodeficiency Virus Type-1 (HIV-1) vaccine research. One promising approach is sublingual (SL) immunization. We examined the effectiveness of SL delivery of two different viral vectors: (i) a recombinant adenovirus (rAd5), and (ii) a Herpes Simplex Virus Type-1 amplicon vector (HSV-1). Initial in vitro videomicroscopy experiments showed that rAd5 particles were trapped in saliva (i.e., that Ad5 was mucoadhesive) - unlike HSV-1 virions, which migrated freely in both saliva and water. In vivo imaging studies in mice revealed that only the rAd5 vector efficiently transduced the SL epithelium. Consistent with this, SL delivery of an rAd5 encoding HIV-1 envelope glycoprotein (Env) resulted in robust antigen-specific antibody responses in plasma and in vaginal washes, whereas SL delivery of a HSV-1 amplicon vector encoding HIV-1 Env failed to elicit Env-specific antibodies. In contrast, both vectors elicited equivalent humoral responses following intramuscular (IM) delivery. Finally, SL delivery of the rAd5:Env vector resulted in elevated levels of Env-specific serum IgA, and vaginal IgA and IgG, when compared to IM delivery of the same vector. These results findings shed light on vector properties (mucoadhesion, penetration of the sublingual barrier) which may be important for the induction of potent humoral immune responses following sublingual vector administration. Our data also show that SL delivery of an Env-encoding rAd5 vector can elicit a potent antigen-specific mucosal antibody response in the absence of adjuvant. Overall, these findings support the further exploration of the SL delivery route for HIV-1 vaccine delivery.


Subject(s)
AIDS Vaccines/administration & dosage , AIDS Vaccines/immunology , HIV-1/immunology , env Gene Products, Human Immunodeficiency Virus/immunology , AIDS Vaccines/genetics , AIDS Vaccines/pharmacokinetics , Adenoviridae/genetics , Adenoviridae/immunology , Administration, Sublingual , Animals , Antibodies, Neutralizing/immunology , Cell Line , Female , Genetic Vectors/administration & dosage , Genetic Vectors/genetics , Genetic Vectors/immunology , HEK293 Cells , HIV Antibodies/blood , HIV Antibodies/immunology , HIV-1/genetics , Herpesvirus 1, Human/genetics , Herpesvirus 1, Human/immunology , Humans , Immunity, Humoral/immunology , Immunity, Mucosal/genetics , Immunity, Mucosal/immunology , Immunoglobulin A/immunology , Immunoglobulin G/immunology , Mice , Mice, Inbred BALB C , Saliva/immunology , Virion/immunology , env Gene Products, Human Immunodeficiency Virus/genetics
6.
J Immunol ; 183(1): 359-69, 2009 Jul 01.
Article in English | MEDLINE | ID: mdl-19542447

ABSTRACT

Lymphocyte migration from blood into lymphoid tissues or to sites of inflammation occurs through interactions between cell surface integrins and their ligands expressed on the vascular endothelium and the extracellular matrix. VLA-4 (alpha(4)beta(1)) is a key integrin in the effective trafficking of lymphocytes. Although it has been well established that integrins undergo functionally significant conformational changes to mediate cell adhesion, there is no mechanistic information that explains how these are dynamically and spatially regulated during lymphocyte polarization and migration. Using dynamic fluorescence resonance energy transfer analysis of a novel VLA-4 FRET sensor under total internal reflection fluorescence microscopy, we show that VLA-4 activation localizes to the lamellipodium in living cells. During T cell migration on VCAM-1, VLA-4 activation concurs with spatial redistribution of chemokine receptor and active Rap1 at the leading edge. Selective inhibition of the activated VLA-4 at the leading edge with a small molecule inhibitor is sufficient to block T cell migration. These data suggest that a subpopulation of activated VLA-4 is mainly localized to the leading edge of polarized human T cells and is critical for T cell migration on VCAM-1.


Subject(s)
Cell Movement/immunology , Integrin alpha4beta1/physiology , Pseudopodia/immunology , Pseudopodia/metabolism , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolism , Vascular Cell Adhesion Molecule-1/metabolism , Amino Acid Sequence , Animals , CHO Cells , Cell Migration Inhibition/genetics , Cell Migration Inhibition/immunology , Cell Movement/genetics , Cell Polarity/genetics , Cell Polarity/immunology , Cells, Cultured , Cricetinae , Cricetulus , Fluorescence Resonance Energy Transfer , Humans , Integrin alpha4beta1/antagonists & inhibitors , Integrin alpha4beta1/genetics , Integrin alpha4beta1/metabolism , Molecular Sequence Data , Protein Conformation , Pseudopodia/genetics , T-Lymphocyte Subsets/cytology , Vascular Cell Adhesion Molecule-1/genetics , Vascular Cell Adhesion Molecule-1/physiology
7.
Blood ; 113(17): 4078-85, 2009 Apr 23.
Article in English | MEDLINE | ID: mdl-19244161

ABSTRACT

Integrin-mediated cell migration is central to many biologic and pathologic processes. During inflammation, tissue injury results from excessive infiltration and sequestration of activated leukocytes. Recombinant human activated protein C (rhAPC) has been shown to protect patients with severe sepsis, although the mechanism underlying this protective effect remains unclear. Here, we show that rhAPC directly binds to beta(1) and beta(3) integrins and inhibits neutrophil migration, both in vitro and in vivo. We found that human APC possesses an Arg-Gly-Asp (RGD) sequence, which is critical for the inhibition. Mutation of this sequence abolished both integrin binding and inhibition of neutrophil migration. In addition, treatment of septic mice with a RGD peptide recapitulated the beneficial effects of rhAPC on survival. Thus, we conclude that leukocyte integrins are novel cellular receptors for rhAPC and the interaction decreases neutrophil recruitment into tissues, providing a potential mechanism by which rhAPC may protect against sepsis.


Subject(s)
Cell Movement/drug effects , Integrins/metabolism , Neutrophils/cytology , Neutrophils/metabolism , Protein C/pharmacology , Animals , Cell Adhesion/drug effects , Cell Line , Cell Survival/drug effects , Humans , Mice , Mice, Inbred C57BL , Neutrophils/drug effects , Recombinant Proteins/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL